Traded Oct 1 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Traded Sep 16, 2026 · Filed Sep 19, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Traded Oct 1 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Melissa B (Epperly, Director) sold ~$608K of Roivant Sciences
Scheduled in advanceMelissa B (Epperly, Director) sold ~$33K of Roivant Sciences
Scheduled in advance